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Cmr2 is the largest and an essential subunit of a
CRISPR RNA-Cas protein complex (the Cmr
complex) that cleaves foreign RNA to protect
prokaryotes from invading genetic elements. Cmr2
is thought to be the catalytic subunit of the effector
complex because of its N-terminal HD nuclease
domain. Here, however, we report that the HD
domain of Cmr2 is not required for cleavage by the
complex in vitro. The 2.3A˚ crystal structure of
Pyrococcus furiosus Cmr2 (lacking the HD domain)
reveals two adenylyl cyclase-like and two a-helical
domains. The adenylyl cyclase-like domains are
arranged as in homodimeric adenylyl cyclases and
bind ADP and divalent metals. However, mutagen-
esis studies show that the metal- and ADP-coordi-
nating residues of Cmr2 are also not critical for
cleavage by the complex. Our findings suggest that
another component provides the catalytic function
and that the essential role by Cmr2 does not require
the identified ADP- or metal-binding or HD domains
in vitro.
INTRODUCTION
Clustered regularly interspaced short palindromic repeats
(CRISPRs) confer adaptive immunity to prokaryotes in their
defense against mobile genetic elements (Barrangou et al.,
2007; Brouns et al., 2008; Garneau et al., 2010; Marraffini and
Sontheimer, 2010b; and see general reviews Deveau et al.,
2010; Karginov and Hannon, 2010; Makarova et al., 2011b; Mar-
raffini and Sontheimer, 2010a; Terns and Terns, 2011). CRISPR
loci found in the genomes of prokaryotes contain short spacer
elements derived from bacteriophages and conjugative plas-
mids and occur in arrays of repeat-spacer-repeat sequences
(Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 2005).
CRISPRs produce small RNAs that recognize homologous
foreign nucleic acids. Adjacent to the CRISPRs are CRISPR-
associated (cas) genes that encode enzymes and factors
involved in all functional stages of CRISPR-mediated immunityStructure 20,(Haft et al., 2005; Makarova et al., 2006, 2011a, 2011b). There
are multiple families of Cas proteins associated with different
types of CRISPR repeats that comprise distinct CRISPR-Cas
immune systems (Haft et al., 2005; Makarova et al., 2006,
2011a, 2011b).
The mechanism of CRISPR-based immunity is divided into
three stages. In the adaptation stage, a short sequence derived
from an invader is integrated into the CRISPR array as a spacer
between two repeats (Barrangou et al., 2007; Garneau et al.,
2010; Horvath et al., 2008). In the expression stage, the CRISPR
array is transcribed into long precursor RNAs from a promoter
found in a leader region preceding the array. The precursor
RNAs are processed into CRISPR RNAs (crRNAs), which are
loaded into effector complexes composed of Cas proteins
(Brouns et al., 2008; Carte et al., 2008; Hale et al., 2008, 2009;
Haurwitz et al., 2010). In the third stage, the effector complexes
use the crRNA to guide the cleavage of invader DNA or RNA
(Hale et al., 2009; Jore et al., 2011; Lintner et al., 2011; Semenova
et al., 2011; Wiedenheft et al., 2011a, 2011b).
Insights into mechanisms of crRNA-mediated targeting of
DNA by several CRISPR-Cas systems are beginning to emerge.
Organisms that contain the Csn-type systems have been shown
to cleave foreign DNA (Garneau et al., 2010), apparently through
the activity of Csn1 (or Cas9) (Sapranauskas et al., 2011).
CRISPR-guided DNA silencing is alsomediated by theCsm-type
Cas proteins, although the mechanism is unknown (Marraffini
and Sontheimer, 2008, 2010b). DNA silencing by the Cse-type
system appears to involve the nuclease-helicase protein Cas3.
This protein has been shown to have single-stranded DNA
endonuclease activity (Mulepati and Bailey, 2011; Sinkunas
et al., 2011) or single-stranded DNA and RNA endo- and exonu-
clease activity (Beloglazova et al., 2011) as well as dsDNA
unwinding activity (Beloglazova et al., 2011; Howard et al.,
2011; Sinkunas et al., 2011). In E. coli, CRISPR interference
requires both Cas3 and a protein complex called Cascade,
which consists of five Cse-type proteins (CasABCDE) (Brouns
et al., 2008). The Cascade complex was shown to bind the target
strand of dsDNA through base-pairing and to displace the
noncomplementary strand (Jore et al., 2011). Cas3 is hypothe-
sized to join the DNA-bound Cascade complex and move along
and cleave the target DNA (Jore et al., 2011; Sinkunas et al.,
2011; Wiedenheft et al., 2011a, 2011b). Cas3 proteins are also
associated with other types of CRISPR-Cas systems and may
function similarly in those systems.545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 545
Figure 1. The RNA Silencing Pathway Mediated by
the Cmr2-Containing Cmr Complex in Pyrococcus
furiosus
(A) The Pyrococcus furiosus Cas protein locus #1. The
processing endoribonuclease Cas6 is shown in gray and
the Cmr proteins are shown in blue. Cmr2 is the largest of
the six Cmr proteins and is a member of the Cas10
superfamily of CRISPR polymerase proteins.
(B) Schematic of crRNA processing, assembly into
the Cmr RNP complex, and guided cleavage of a target
RNA. The pre-crRNA transcript is initially processed by
Cas6 within the repeat sequence to form intermediate
crRNAs which contain 8 nt of the repeat at the 50 end
(called the tag; shown in black) and the remaining 22 nt
of repeat at the 30 end. These intermediate crRNAs are
then processed by an unknown mechanism into mature
crRNAs, which retain the 50 tag sequence upstream of 31
or 37 nts of the spacer sequence. The mature crRNAs
are loaded on the Cmr effector complex and guide
the recognition and cleavage of target RNAs through
base-pairing. The Cmr complex cleaves the target at the
nucleotide opposite to that 14nt from the 30 end of the
crRNA.
(C) In vitro cleavage activity of the reconstituted P. furiosus Cmr complex containing the full-length Cmr2 or an N-terminal domain truncated mutant,
Cmr2dHD. The Cmr complex (1 mM) containing full-length Cmr2 (wt), no Cmr2 (-Cmr2) or Cmr2 lacking the N-terminal HD domain (Cmr2dHD) was incubated
with either the 39 or 45 nucleotide crRNA, followed by addition of radiolabeled target RNA (indicated by an open arrow). – lanes contain no crRNA or proteins.
The 39 nt crRNA guides cleavage that results in a 20 nt cleavage product while the 45 nt crRNA results in a 14 nt cleavage product (indicated by asterisks).
crRNA/target RNA duplexes are indicated by closed arrows.
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Crystal Structure of Cmr2The Cmr (Cas RAMP module)-type effector complex recog-
nizes and destroys complementary RNAs (Hale et al., 2012,
2009). This CRISPR-Cas effector complex has been found to
cleave target RNAs in vivo, but has also been reconstituted
and analyzed in vitro (Hale et al., 2012, 2009). The complexes
characterized from Pyrococcus furiosus (Pf) include six
proteins, Cmr1–6 (Figure 1A), and crRNAs of 39 and 45 nucleo-
tides (nts) (Hale et al., 2012, 2009). Each of the six Cmr proteins
and at least one crRNA is essential for function. As is the case for
some other CRISPR-Cas systems, crRNAs associated with Cmr
complexes contain an 8 nt repeat sequence tag at the 50 end
upstream of an invader-targeting or guide element of variable
sequence (Brouns et al., 2008; Lintner et al., 2011; Marraffini
and Sontheimer, 2010b). The 50 8 nt repeat tag is generated by
Cas6, which binds to the CRISPR locus transcript and cuts
within each repeat 8 nt upstream of the guide element (Carte
et al., 2008). The Cmr complex cleaves the target RNA 14 nucle-
otides from the 30 end of the bound crRNA (Hale et al., 2009).
Interestingly, although the cleavage reaction requires specific
divalent metals, the complex cleaves on the 50 side of the phos-
phodiester bond and produces a 30, or 20,30 cyclic phosphate
terminus and a 50 OH terminus (Hale et al., 2009). These products
are reminiscent of metal-independent catalysis, in which the 20
OH of ribose is used as a nucleophile to attack the adjacent 30
phosphate and break the RNA backbone (Yang, 2011). Little is
known about how the Cmr complex assembles, interacts with
the crRNA and substrate RNA, and finally facilitates RNA
cleavage.
Cmr2 is the largest of the six proteins in the Cmr complex and
a member of COG1353 (Haft et al., 2005; Makarova et al., 2002).
It belongs to the greater Cas10 family of proteins (Makarova
et al., 2011b). Many of the COG1353 proteins are predicted to
have a permuted histidine-aspartate (HD) superfamily hydrolase546 Structure 20, 545–553, March 7, 2012 ª2012 Elsevier Ltd All righdomain (predicted nuclease domain) at the N terminus, a zinc
finger domain, and a ferredoxin-like fold similar to the catalytic
domain of many polymerases and nucleotide cyclases
(Makarova et al., 2011b). In addition, the ferredoxin-like fold in
Cmr2 contains a degenerate GGDEF (GGDD) motif similar to
that found in nucleotide cyclases (Anantharaman et al., 2010).
The acidic residues of the GGDEF motif are known to bind diva-
lent metal ions in these enzymes (Anantharaman et al., 2010;
Wang et al., 2011). Cmr2 had been predicted to catalyze RNA/
DNA polymerization for some aspect of CRISPR-Cas function
(Anantharaman et al., 2010; Haft et al., 2005; Makarova et al.,
2006); however, the only experimentally observed function of
Cmr2 is its essential role in crRNA-mediated RNA cleavage by
the Cmr1-6 complex (Hale et al., 2009) (Figure 1). Also based
largely on its predicted functional domains, Cmr2 is considered
the most likely Cmr complex subunit responsible for target
RNA cleavage.
Here, we biochemically and structurally characterized Pf
Cmr2. We found that a truncated Cmr2 that lacks the N-terminal
predicted HD domain (Cmr2dHD) is fully functional in RNA
cleavage as part of the Cmr complex. The structure of Cmr2dHD
in complex with adenosine diphosphate (ADP) contains a full
and a partial adenylyl cyclase-like domain; together, the two
domains form a nucleotide and divalent metal binding pocket.
Cmr2dHD possesses some of the residues required for nucleo-
tide cyclization in adenylyl cyclases. However, it does not
exhibit detectable ATP hydrolysis activity in vitro. Furthermore,
mutation of the conserved acidic residues that interact with
bound metal ions or ADP does not affect the ability of the
reconstituted Cmr complex containing Cmr2dHD to cleave
target RNA. Implications of these findings in the biochemical
mechanism of the Cmr-mediated RNA silencing reaction are
discussed.ts reserved








Space group P212121 P212121 P212121
a 70.6 73.2 73.0
b 80.2 85.0 85.6

















Redundancy 6.7 (4.4) 6.7 (5.1) 3.5 (1.7)
Completeness (%) 90.7 (65.7) 96.9 (88.2) 97.3 (71.4)
I/s(I) 27.6 (2.49) 25.9 (2.28) 30.5 (9.43)
Rsym(%) 8.3 (55) 7.4 (72) 8.9 (49.0)
Refinement statistics













No. of amino acids 550 550
Root-mean-square deviations (rmsd)
Bond length (A˚) 0.014 0.018
Bond angle () 1.093 1.508
Ramachandran plot of protein residues
Preferred regions (%) 96.2 95.9
Allowed regions (%) 3.8 4.1
Disallowed region (%) 0.0 0.0
Values in parentheses are for the last resolution shell.
aThis data set was only used for identification of bound metals and the
structure was not further refined.
Structure
Crystal Structure of Cmr2RESULTS
The Predicted HD Domain of Cmr2 Is Not Required
for Target RNA Cleavage Activity
Sequence alignment of Pf Cmr2 with other Cmr2 proteins using
PSI-BLAST and COBALT (Papadopoulos and Agarwala, 2007)
showed that the N-terminal 215 amino acids comprise
a permuted HD hydrolase domain (Makarova et al., 2002; see
Figure S1 available online). To test the predicted function of
Cmr2 and the HD domain in RNA cleavage, we constructed
a truncated version of Cmr2, Cmr2dHD, in which the first 215
amino acids are removed. The Cmr1-6 complex was reconsti-
tuted with either the wild-type or Cmr2dHD protein and tested
in a previously established activity assay (Hale et al., 2009).
The complex containing Cmr2dHD showed similar cleavage
activity to that containing the wild-type protein, producing the
correctly sized 14 and 20 nt target RNA cleavage products
when reconstituted with the 45 and 39 nt crRNA, respectively
(Figure 1C). This result indicates that the putative HD domain is
not required for RNA cleavage by the complex. Since Cmr2dHD
expression is more robust than the wild-type Cmr2, all further
experiments were performed using Cmr2dHD.
Overview and Domain Structures of Cmr2dHD
The crystal structure of Cmr2dHD without bound ADP was
solved by single wavelength anomalous diffraction phasing
methods using L-Selenomethionine (SeMet)-substituted protein
crystals and refined to 2.4 A˚ resolution (Table 1). The crystal of
ADP-bound Cmr2dHD has the same space group and unit cell
dimensions as those of the ADP-free crystal and its structure
was refined to 2.3 A˚ resolution (Table 1). Cmr2dHD was crystal-
lized in an orthorhombic space group (P212121) with one protein
in the asymmetric subunit but without extensive interfaces
among its symmetry mates (Table 1). The ADP-free and ADP-
bound structures of Cmr2dHD do not differ in overall structure,
and the ADP-bound structure is used for subsequent discus-
sions on general structural features of Cmr2dHD. Cmr2dHD
structure shows a flat triangular arrangement of four structural
domains (D1, D2, D3, and D4) connected by loops (Figures 2A,
2B, and 2E). Domains D1 and D3 are ferredoxin(-like) domains
positioned side-by-side and each is followed by a small a-helical
domain, D2 and D4, respectively.
The N-terminal domain (D1, residues 216–503) is the largest of
the four domains and is composed of nine a helices and three
b strands. The three b strands (b1b3) and two of the nine
a helices (a2 and a6) form a ferredoxin-like fold short of a b strand
(Figure 2C). (If the loop connecting a3 to a4 were replaced by
a b strand, D1would be a bona fide ferredoxin fold.) Incorporated
into D1 and below the ferredoxin-like fold is a zinc finger, as
previously predicted (Figure 2A) (Makarova et al., 2011b). The
zinc ion is coordinated by four cysteine residues coming from
two CXXC motifs, one at the loop connecting a10 and a11
(Cys448 and Cys451) and one at the N terminus of a11 helix
(Cys478 and Cys481) (Figure S4), in a manner similar to the
treble-clef zinc finger of the ribosomal protein S14 (Grishin,
2001; Wimberly et al., 2000).
Domain D3 (residues 593–764) is the most conserved domain
of Cmr2dHD and contains a ferredoxin fold (Figure 2C). The
ferredoxin fold of D3 is a typical babbab structure comprisedStructure 20,of b4b7 and a18–a19 (Figures 2A and 2C). The ferredoxin
fold is extended by secondary structure elements a20 to b9
leading to an extended seven-stranded central sheet sand-
wiched by three helices. Short loops connect secondary struc-
tures at the lower region of the D3 domain while most of the
upper region loops are disordered (Figures 2A and 2B).
Surprisingly, despite limited sequence similarity (16% iden-
tity) between the D1 and D3 domains, their three-dimensional
structures superimpose well, including regions beyond the ferre-
doxin fold (root-mean-square-deviation, or rmsd, is 2.6 A˚ for 102
Ca atoms) (Figure 2D). This finding suggests a domain duplica-
tion event followed by diversification.
Cmr2dHD Resembles Homodimeric Adenylyl Cyclases
Among available structures, Cmr2dHD has the highest similarity
to nucleotide cyclases when aligned using the DALI multiple545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 547
Figure 2. Crystal Structure ofP. furiosusCmr2dHD
(A) Overview and domain structure of Cmr2dHD.
Cmr2dHD is a flat, triangular, four-domain protein. The
N-terminal domain D1 (blue) contains a ferredoxin-like fold
(which contains a P loop) and a zinc finger. The D3 domain
(orange) contains a ferredoxin fold that includes
a conserved GGDD motif on a b hairpin and a P loop
structure. Domains D2 (green) and D4 (red) are exclusively
a-helical.
(B) Topology of the Cmr2dHD structure with the same
coloring scheme as (A). Arrows represent b sheets and
cylinders represent a helices. Dashed lines represent
disordered regions. The P loops of D1 and D3, the
b hairpin of D3, and the zinc finger of D1 are indicated.
(C) Cmr2dHD contains two homologous ferredoxin folds
(colored in blue and orange for the D1 and D3 domains,
respectively). The D1 ferredoxin-like fold lacks the
b hairpin but maintains the P loop (purple). The D3 domain
contains both the b hairpin (yellow) and P loop (purple).
(D) D1 and D3 domains are homologous. The two domains
have a root-means-square-deviation of 2.6 A˚.
(E) Electrostatic surface potential of Cmr2dHD bound
with adenosine diphosphate (ADP).
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Crystal Structure of Cmr2structural alignment server (http://ekhidna.biocenter.helsinki.fi/
dali_server/). The best alignment was obtained with domain D3
of Cmr2dHD and a monomer of Mycobacterium tuberculosis
(Mt) adenylyl cyclase (Protein Data Bank [PDB] 1YBU) (Sinha
et al., 2005). Despite a 14% amino acid sequence identity
between the two proteins, the alignment Z-score is 11.9 and
the rmsd is 2.9 A˚ (166 aligned Ca atoms). The homologous
domain D1 also resembles the adenylyl cyclase monomer, but
to a lesser degree (Z-score 10.0, rmsd 2.1). Together, domains
D1 and D3 have an overall resemblance to the dimeric form of
Mt adenylyl cyclase (Figures 3A and 3C). Each Mt adenylyl
cyclase monomer consists of a typical ferredoxin fold (babbab)
plus an extra ababb folding unit at the C-terminal end, leading
to a continuous seven-stranded b sheet sandwiched by three
a helices on one side and one a helix on the other (Figure 3C)
(Artymiuk et al., 1997; Sinha et al., 2005). Domain D3 has the
same seven-stranded b sheet and flanking helices with only
a small difference in the C-terminal folding unit (Figure 3A).
Domain D3 has an abb while Mt adenylyl cyclase has an ababb
element. Domain D1, on the other hand, lacks the entire
C-terminal folding unit except for the a helix a9. Thus, due to548 Structure 20, 545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reservedthe missing b strand in its ferredoxin fold and
the C-terminal folding unit, D1 contains
a three-stranded rather than a seven-stranded
b sheet sandwiched by helices (Figure 3A). In
addition, the relative orientation of the ferre-
doxin fold in D1 with respect to that in D3 is
significantly different from that between the
two monomers of Mt adenylyl cyclase. As a
result, the D1 and D3 domains form a more
open interface than that between the twomono-
mers of Mt adenylyl cyclase.
A b hairpin inMt adenylyl cyclase contains the
degenerate GGDEF motif (GDGF) that is known
to facilitate catalysis of phosphate cyclization(Figure 3D, Sinha et al., 2005). Adjacent to the b hairpin is the
P loop structure with residues that participate in binding of the
nucleotide (Sinha et al., 2005; Tesmer et al., 2000) (Figure 3D).
The same architecture is observed in the D3 (but not in the D1)
domain of Cmr2dHD (Figure 3B). The D3 b hairpin contains a
GGDD sequence motif (Gly671–Asp674) and is positioned next
to the P loop (Gly601–Gly605) (Figures 3B, 3D, and 5A). In the
D1 domain, the region corresponding to the GGDEF b hairpin
is replaced by an insertion of two a helices (a3 and a4), although
the P loop is maintained (Figure 3B). The similarity that we found
between the D3 domain of Cmr2 and Mt adenylyl cyclase
monomer suggested that Cmr2dHD may bind nucleotides and
metal ions.
Cmr2dHD Binds Nucleotides and Metal Ions
To address how Cmr2dHD binds ADP, we compared ADP-free
and ADP-bound structures. No major conformational changes
were observed between the unbound and nucleotide-bound
Cmr2dHD except for a loop-to-helix transition near the P loop
of D1 domain (a1, residues 229–234). This region is unstructured
but forms a short helix upon ADP binding (Figure 4). Interestingly,
Figure 3. Structure of Cmr2dHDBoundwith AdenosineDiphosphate
and Ca2+ and Structure Comparison with Mycobacterium tubercu-
losis Adenylyl Cyclase
(A) Cmr2dHD binds to adenosine diphosphate (ADP) (stick model) at its
interface between D1 and D3 domain. Cyan spheres represent bound Ca2+
ions and red spheres represent water oxygen atoms.
(B) Close-up view of ligand binding site of Cmr2dHD. ADP interacts with the
P-loops (purple) of the D1 domain and the bound Ca2+ atoms interact with the
b hairpin (yellow) and P loop (purple) of domain D3.
(C) Crystal structure of the AB dimer (colored in blue and orange, respectively)
of theMycobacterium tuberculosis (Mt) Rv1900c adenylyl cyclase bound with
a,b-methyleneadenosine 50-triphosphate (AMPCPP) (Sinha et al., 2005;
1YBU). The Mt adenylyl cyclase (Mt Ac) dimer is displayed with its monomer A
(orange) in the same orientation as D3 domain of Cmr2dHD.
(D) Close-up view of ligand binding site of Mt adenyly cyclase. AMPCPP
interacts primarily with the b hairpin (yellow) and P loop (purple) of monomer A
in Mt adenylyl cyclase.
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Crystal Structure of Cmr2although ADP is localized to the expected binding site near the
GGDD b hairpin and the P loop on the D3 domain, it is bound
in a different orientation in Cmr2dHD than in Mt adenylyl cyclase
(Figures 3B, 3D, 5B, and 5C) (Sinha et al., 2005). In Mt adenylyl
cyclase, an ATP analog, a,b-methyleneadenosine 50-triphos-
phate (AMPCPP), inserts into a binding pocket formed by hydro-
phobic residues of monomer B and stacks on the peptide plane
of Gly345 and Asp346 of monomer A (Figure 5C) (Sinha et al.,
2005). The bound ADP in Cmr2dHD is also stabilized by residues
from both domains D1 and D3. However, the details of the inter-
action and the location of the bound ATP are different between
the two structures. The strictly conserved Asp674 of the GGDD
motif of Cmr2dHD interacts with ADP by contacting its 20 ribose
hydroxyl group (Figures 5A and 5B). The adenine ring of ADP is
sandwiched by Tyr669 of D3 b hairpin, and Val229 and Ile233
of a1 in D1. It is clear that the loop-to-helix transition of a1 is crit-
ical for Val229 and Ile233 to stabilize the bound ADP. Ser250 and
Ser246 of a2 make hydrogen bond contacts to the N6 and N1
atoms of the ADP. The phosphate backbone is stabilized by
bound metal ions and water molecules that further interact with
protein residues (Figures 3A and 5B). As a result, the ADP is
closer to the P loop of the D1 domain of Cmr2dHD than AMPCPP
is to that of the Mt adenylyl cyclase monomer B (Figures 3B and
3D). The observed interactions suggest Cmr2 is specific for theStructure 20,adenine base. This is supported by the fact that Cmr2dHD
crystals soaked with GTP, UTP, or CTP did not yield electron
densities corresponding to these nucleotides (data not shown).
As in adenylyl cyclases, the GGDD motif of Cmr2dHD also
binds divalent ions (Figure 5B). Metal binding sites were first sug-
gested by high levels of Fourier difference densities and later
confirmed by anomalous difference densities obtained from
Mn2+ soaked crystals (Figure S2). Weaker difference density
around the metal sites was also observed that could be attrib-
uted to coordinated water molecules. Since the best crystals
were grown in the presence of 0.2 M Ca2+, we placed Ca2+ at
the binding sites identified from the Mn2+-soaked crystals. The
two Ca2+ ions are separated by 3.5 A˚ and are coordinated to
protein, nucleotide ligands, and ordered water molecules (Fig-
ure 5B; Figure S2). Although the precise coordination geometry
cannot be established at the resolution of the structure, both
Ca2+ ions appear to have an octahedral coordination geometry
(Figure 5B). The B site calcium is coordinated to Asp673 of the
GGDD motif, Asp600 and the amide of Gly601 of the P loop,
and two or possibly three ordered water molecules (Figure 5B).
Unlike adenylyl cyclases where metal A coordinates with the
pro-R oxygen of the a-phosphate, which was postulated to facil-
itate the nucleophilic attack of the 30-hydroxyl group on the
a-phosphate (Figure 5C), the calcium ion at the A metal site is
coordinated to an oxygen of the b-phosphate of ADP, three
aspartates, and two ordered water molecules (Figure 5B). The
structural difference in nucleotide binding observed between
Cmr2dHD and Mt adenylyl cyclase is consistent with the fact
that Cmr2dHD (alone or in the context of the Cmr complex)
does not release detectable phosphate or pyrophosphate
when incubated with g32P-ATP or a32P-ATP (Figure S5).
Metal-Coordinating Aspartates of Cmr2 Are Not
Required for Target RNA Cleavage Activity
The Asp cluster that coordinates both metals in Cmr2dHD is
highly conserved (Figure 5A; Makarova et al., 2002). We hypoth-
esized that the metal-binding site could be involved in phospho-
diester bond cleavage as is observed in metal-dependent
ribonucleases (Yang, 2011). Mutation of the catalytic metal-
coordinating Asp residues in the RNase H family of nucleases
abolished their RNA cleavage activity (Nowotny et al., 2005;
Glavan et al., 2006). We mutated the Asp residues and tested
crRNA-guided RNA cleavage activity of the Cmr complex con-
taining the Cmr2dHD mutants. To our surprise, mutation of
Asp600, Asp602, Asp673, or Asp673 and Asp674 did not abolish
the cleavage activity of the Cmr complex (reconstituted with
either the 39 nt or the 45 nt crRNA) (Figure 6). We further mutated
other highly conserved residues that may or may not be involved
in nucleotide binding. Again, mutants of Ser246, Ser250, Tyr669,
Asp460 and His762 (Figure 6), or Glu475 and Lys739, or Lys744
(Figure S3) all maintained a significant level of catalytic activity.
We thus conclude that the nucleotide andmetal binding residues
of Cmr2 are not required for Cmr complex-mediated target RNA
cleavage.
DISCUSSION
The Cmr2 protein from Pyrococcus furiosus is a large, multido-
main protein whose sequence contains features reminiscent of545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 549
Figure 4. Overlay of the ADP-Bound and Unbound
Structures of Cmr2dHD
Conformational change is restricted to widening of the
distance between the lower part of the D1 andD2 domains
and the formation of the a1 helix at the nucleotide binding
site (inset). ADP-bound is indicated in green and unbound
is indicated in black.
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Crystal Structure of Cmr2DNA polymerases and nucleotide cyclases, which originally led
to its classification as a CRISPR-Cas system polymerase
(Makarova et al., 2002, 2011a, 2006). The crystal structure of
a truncated but functional Cmr2 protein, Cmr2dHD, has
revealed that the resemblance of Cmr2dHD to DNA polymerases
is limited to a babbab fold and secondary elements for binding
divalent metals and nucleotides (Figure 2). Cmr2 more closely
resembles homodimeric adenylyl cyclases in terms of protein
fold, ligand binding sites, and overall architecture (Figures 3
and 5). In addition, a zinc finger and two a-helical domains
surround the adenylyl cyclase-like core in Cmr2.
D3 is the most conserved domain of Cmr2dHD. It contains
a conserved GGDD b hairpin and an adjacent P loop that closely
resemble those of cyclases (Mou et al., 2009; Sinha et al., 2005).
The less conserved D1 domain also has a cyclase-like fold but
lacks the equivalent b hairpin. The interface of the two domains
forms ametal and nucleotide binding site analogous to that of Mt
adenylyladenylyl cyclase (Figures 3 and 5). Two divalent metal
ions bound at the b hairpin/P loop are coordinated by three
phylogenetically conserved aspartate residues (Asp600,
Asp673, and Asp674) at this site (Figure 5). The bound ADP
forms multiple hydrogen bond and hydrophobic interactions
with highly conserved residues from both the b hairpin/P loop
of D3 and the P loop of D1. Despite their overall resemblance,
important differences in domain orientation, metal coordination,
and nucleotide location are observed between Cmr2dHD andMt
adenylyl cyclase. The interface between D1 and D3 of Cmr2dHD
is more open than that between the two subunits of the Mt ad-
enylyl cyclase. The metal A of Cmr2dHD is coordinated to the
b-phosphate rather the a-phosphate pro-R oxygen as in Mt ad-
enylyl cyclase. Thus, it is unlikely that Cmr2 supports catalysis of
cyclization as Mt adenylyl cyclase does.
We discovered in this work that key conserved features of
Cmr2 are not required for cleavage of target RNAs by the Cmr
complex. The HD domain was hypothesized to serve as
a nuclease domain (Makarova et al., 2002, 2011a). Its removal
from Cmr2, however, did not disrupt crRNA-guided RNA
nuclease activity of the Cmr complex (Figure 1C). Furthermore,
mutations of either nucleotide- or metal-binding aspartate resi-
dues also did not eliminate RNA cleavage activity. The HD
domain and nucleotide and metal binding sites of Cmr2 are550 Structure 20, 545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reservedconserved and it was therefore somewhat
surprising that mutations did not significantly
impair the ability of Cmr2 to assemble into
catalytically active Cmr complexes capable of
cleaving target RNAs in vitro (Figure 6). Con-
ceivably, these domains of Cmr2 are critical
for a function that we did not assay; for example,
a regulatory (perhaps efficiency or signaling)role in Cmr activity in vivo. These possibilities await confirmation
from further biochemical and structural data.
Our findings suggest that Cmr2 is unlikely to be the catalytic
subunit of the Cmr complex and refocus the question of the iden-
tity of the catalytic subunit. Full activity of the Cmr complex
requires five additional Cmr proteins (Hale et al., 2009). Four of
these proteins (Cmr1, Cmr3, Cmr4, and Cmr6) belong to the
greater RAMP family of Cas proteins (Haft et al., 2005; Makarova
et al., 2002). Several RAMP proteins have been recently deter-
mined to function as metal-independent riboendonucleases
(Brouns et al., 2008; Carte et al., 2008; Gesner et al., 2011; Haur-
witz et al., 2010; Wang et al., 2011) and our findings suggest that
that the catalytic activity of the Cmr effector complex may reside
in one or more of the RAMP proteins of the complex.
EXPERIMENTAL PROCEDURES
Protein Preparation
In order to construct the Cmr2dHD truncation, PCR was performed from the
previously described PF1129-containing pET200D-TOPO plasmid (Hale et al.,
2009) using 50-CACCATGGTTAAGGATCCCACTTTGCTCAGG-30 as a forward
primer, and 50-GTCATGCTAGCCATGTCATGGAAACACCTCCGCGTCCG-30
as the reverse primer. PCR was performed using the Expand High Fidelity
PCR system (Roche) as recommended. The resulting PCR product was cloned
into the pET200D-TOPO plasmid using the manufacturer’s protocol (Invitro-
gen). Resulting plasmids were sequenced to confirm the truncation. Point
mutations were made using Quikchange (Agilent). The proteins were ex-
pressed in Escherichia coliBL21 RIPL cells (Agilent Technologies, Santa Clara,
CA). Cells were resuspended in lysis buffer (25 mM sodium phosphate [pH
7.5], 1.0 M NaCl, 10% [v/v] glycerol, 5.0 mM b-mercaptoethanol, and
0.2 mM phenylmethylsulfonyl fluoride) and disrupted by sonication. The cell
debris was cleared by centrifugation. The supernatant was loaded onto a
Ni-NTA column equilibrated with the lysis buffer supplemented with 5 mM
imidazole. The column was washed with the lysis buffer containing 25 mM
imidazole and the protein was eluted by increasing imidazole to 350mM. Frac-
tions containing the protein were pooled and loaded onto a Superdex 200
(Hiload 26/60, GE Healthcare) size-exclusion chromatography column that
had been equilibrated with 20 mM Tris-HCl (pH 7.4), 500 mM NaCl, 5% (v/v)
glycerol, and 5 mM b-mercaptoethanol. Fractions corresponding to the puri-
fied protein were pooled and concentrated.
Crystallization of Native and L-Selenomethionine-Labeled
Cmr2dHD
Native and L-Selenomethionine (SeMet)-labeled Cmr2dHD were crystallized
at 30C by vapor diffusion method using hanging drops. Equal volumes of
Figure 5. Differences in Interaction of the
Conserved Residues of Cmr2dHD and Mt Adenylyl
Cyclase with Nucleotide and Metal Ions
(A) Multiple sequence alignment of the most conserved
portion of selected Cmr2 proteins across archaea and
bacteria. Secondary structures are colored in the same
scheme as in Figure 2 and are shown above the
alignment (cylinders for a helices, arrows for b strands,
and lines for loops). Levels of conservation in amino
acids are indicated by shades of blue with darker blue
corresponding to greater conservation. The locations of
the P loop and b hairpins are indicated. Residues that
are mutated in Figure 6 or Figure S3 are indicated by
asterisks.
(B) Detailed interactions at the ligand binding site of Pf
Cmr2dHD. Residues within 3.5 A˚ of the bound ligands
are displayed using the same color scheme as in Fig-
ure 2. Cyan spheres represent bound Ca2+ ions and red
spheres represent water oxygen atoms.
(C) Detailed interactions of Mt adenylyl cyclase active
site. Residues are similarly identified and the purple
sphere represents bound Mn2+.
See also Figures S2, S3, and S5.
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Crystal Structure of Cmr2protein and well solution (0.1 mMHEPES sodium [pH 7.4], 0.2 M calcium chlo-
ride dihydrate, 28% [v/v] polyethylene glycol 400) were combined into 2.4 ml
droplets on coverslips. Crystals formed in 6–7 days and had a hexagonal prism
shape with typical dimensions of 0.4 mm 3 1 mm 3 0.4 mm.
Data Collection and Structure Determination
Crystals were cryoprotected in a buffer containing 0.1 mMHEPES sodium (pH
7.4), 0.2 M calcium chloride dihydrate, 15% (v/v) polyethylene glycol 400,
1.0 M sodium chloride prior to being mounted on goniometer head. For the
ADP-bound structure, 2 mM ADP was added to the cryoprotecting solution.
For the Mn2+-bound structure, native crystals were soaked in the cryo solution
containing 0.2 MMn2+ instead of Ca2+. X-ray diffraction data were collected at
the Southeast Regional Collaborative Access Team (SER-CAT) beamline 22ID
or 22BM. Data were indexed, integrated, and scaled using the HKL2000 soft-
ware package (Otwinowski and Minor, 1997). The space group of the crystals
was determined to be P212121 with one protein in the asymmetric unit and the
cell dimensions are listed in Table 1. Phases for the Cmr2dHD structure were
determined from a highly redundant single-wavelength anomalous dispersion
(SAD) data set at the anomalous peak of selenium from a SeMet-labeled
crystal. Structure determination, iterative model building, and structure refine-
ment were done using the PHENIX (Adams et al., 2010) and COOT programs
(Emsley andCowtan, 2004). In a later stage of refinement, a bound zinc ionwas
identified at the center of the cysteine cluster from a difference anomalous
Fourier peak (>3.5 s) using the selenium SAD data set. The final refinementStructure 20,statistics are shown in Table 1. The structure of the ADP-bound Cmr2dHD
was obtained by molecular replacement using the ADP-free Cmr2dHD struc-
ture as the search probe.
RNA-Cleavage Reactions
Purified Cmr2 wild-type, Cmr2dHD, or a Cmr2dHDmutant was combined with
Cmr1, Cmr3, Cmr4, Cmr5, and Cmr6 in equal molar amounts to a final concen-
tration of 50 mM in 20 mM Tris-HCl (pH 7.4), 500 mM NaCl, 5% (v/v) glycerol,
and 5 mM b-mercaptoenthanol. The reconstituted complex was diluted to
1 mMwhen being incubated with either the 39-mer or the 45-mer Pf7.01 crRNA
(Hale et al., 2009) at 0.1 mM for 30 min at 70C in 20 mM sodium cacodylate
(pH 6.2), 20 mMMgCl2 in the presence of 1 unit of SUPERase-In RNase inhib-
itor. RNA cleavage reaction was initiated by adding 0.016 mM 50-radiolabeled
target RNA and the reaction was incubated for 1 hr at 70C. The reaction was
quenched by the addition of 96% formamide dye. The cleavage products
were resolved on a 15% polyacrylamide, 7 M urea gel and visualized by
phosphorimaging.ACCESSION NUMBERS
Coordinates and structure factors have been deposited in the Protein Data
Bank with accession number 3UR3 for the Cmr2dHD structure and 3UNG
for the ADP-bound Cmr2dHD structure.Figure 6. Mutational Analysis of theNucleo-
tide and Metal-Binding Residues of
Cmr2dHD
Reconstituted Cmr complexes (Cmr1-6, 1 mM)
containing no Cmr2 (-Cmr2), Cmr2dHD, or
mutants thereof (as indicated) were incubated with
crRNAs (0.1 mM) of 39 nt or 45 nt (as indicated) for
30 min before the addition of g32P-labeled target
RNA (labeled by an open arrow). The reaction
mixtures were incubated for 1 hr and analyzed on
15% denaturing polyacrylamide gel. The ‘‘–’’ lanes
contain no crRNA or proteins. Cleavage products
are indicated by asterisks. Target RNA/crRNA
duplexes are indicated by a closed arrow.
545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 551
Structure
Crystal Structure of Cmr2SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and one table and can be found
with this article online at doi:10.1016/j.str.2012.01.018.
ACKNOWLEDGMENTS
This work was supported by National Science Foundation grant MCB0817638
to H.L., American Heart Association predoctoral fellowship 11PRE7090000 to
A.C., and National Institutes of Health Grant R01 GM54682 to M.T. and R.T.
We thank Paul Griffith (UGA) for technical assistance in generating the Cmr2
HD domain mutation. X-ray diffraction data were collected from the Southeast
Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the
Advanced Photon Source, Argonne National Laboratory. Supporting institu-
tions for APS beamlines may be found at http://necat.chem.cornell.edu/ and
http://www.ser-cat.org/members.html. Use of the Advanced Photon Source
was supported by the U. S. Department of Energy Office of Science, Office
of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.
Received: November 24, 2011
Revised: January 10, 2012
Accepted: January 15, 2012
Published: March 6, 2012
REFERENCES
Adams, P.D., Afonine, P.V., Bunko´czi, G., Chen, V.B., Davis, I.W., Echols, N.,
Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010).
PHENIX: a comprehensive Python-based system for macromolecular struc-
ture solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221.
Anantharaman, V., Iyer, L.M., and Aravind, L. (2010). Presence of a classical
RRM-fold palm domain in Thg1-type 30- 50nucleic acid polymerases and the
origin of the GGDEF and CRISPR polymerase domains. Biol. Direct 5, 43.
Artymiuk, P.J., Poirrette, A.R., Rice, D.W., andWillett, P. (1997). A polymerase I
palm in adenylyl cyclase? Nature 388, 33–34.
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau,
S., Romero, D.A., and Horvath, P. (2007). CRISPR provides acquired resis-
tance against viruses in prokaryotes. Science 315, 1709–1712.
Beloglazova, N., Petit, P., Flick, R., Brown, G., Savchenko, A., and Yakunin,
A.F. (2011). Structure and activity of the Cas3 HD nuclease MJ0384, an
effector enzyme of the CRISPR interference. EMBO J. 30, 4616–4627.
Bolotin, A., Quinquis, B., Sorokin, A., and Ehrlich, S.D. (2005). Clustered regu-
larly interspaced short palindrome repeats (CRISPRs) have spacers of extra-
chromosomal origin. Microbiology 151, 2551–2561.
Brouns, S.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J., Snijders,
A.P., Dickman, M.J., Makarova, K.S., Koonin, E.V., and van der Oost, J. (2008).
Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321,
960–964.
Carte, J., Wang, R., Li, H., Terns, R.M., and Terns, M.P. (2008). Cas6 is an en-
doribonuclease that generates guide RNAs for invader defense in prokaryotes.
Genes Dev. 22, 3489–3496.
Deveau, H., Garneau, J.E., and Moineau, S. (2010). CRISPR/Cas system and
its role in phage-bacteria interactions. Annu. Rev. Microbiol. 64, 475–493.
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular
graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132.
Garneau, J.E., Dupuis, M.E., Villion, M., Romero, D.A., Barrangou, R., Boyaval,
P., Fremaux, C., Horvath, P., Magada´n, A.H., and Moineau, S. (2010). The
CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid
DNA. Nature 468, 67–71.
Gesner, E.M., Schellenberg, M.J., Garside, E.L., George, M.M., and
Macmillan, A.M. (2011). Recognition and maturation of effector RNAs in
a CRISPR interference pathway. Nat. Struct. Mol. Biol. 18, 688–692.
Glavan, F., Behm-Ansmant, I., Izaurralde, E., andConti, E. (2006). Structures of
the PIN domains of SMG6 and SMG5 reveal a nuclease within the mRNA
surveillance complex. EMBO J. 25, 5117–5125.552 Structure 20, 545–553, March 7, 2012 ª2012 Elsevier Ltd All righGrishin, N.V. (2001). Treble clef finger—a functionally diverse zinc-binding
structural motif. Nucleic Acids Res. 29, 1703–1714.
Haft, D.H., Selengut, J., Mongodin, E.F., and Nelson, K.E. (2005). A guild of 45
CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes
exist in prokaryotic genomes. PLoS Comput. Biol. 1, e60.
Hale, C., Kleppe, K., Terns, R.M., and Terns, M.P. (2008). Prokaryotic silencing
(psi)RNAs in Pyrococcus furiosus. RNA 14, 2572–2579.
Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns,
R.M., and Terns, M.P. (2009). RNA-guided RNA cleavage by a CRISPR
RNA-Cas protein complex. Cell 139, 945–956.
Hale, C.R., Majumdar, S., Elmore, J., Pfister, N.T., Compton, M.M., Olson, S.,
Resch, A.M., Glover, C.V.C., Graveley, B.R., Terns, R.M., et al. (2012).
Essential features and rational design of CRISPR RNAs that function with
the Cas RAMP module complex to cleave RNAs. Mol. Cell 45, 292–302.
Haurwitz, R.E., Jinek, M., Wiedenheft, B., Zhou, K., and Doudna, J.A. (2010).
Sequence- and structure-specific RNA processing by a CRISPR endonu-
clease. Science 329, 1355–1358.
Horvath, P., Romero, D.A., Couˆte´-Monvoisin, A.C., Richards, M., Deveau, H.,
Moineau, S., Boyaval, P., Fremaux, C., and Barrangou, R. (2008). Diversity,
activity, and evolution of CRISPR loci in Streptococcus thermophilus.
J. Bacteriol. 190, 1401–1412.
Howard, J.A., Delmas, S., Ivancic-Bace, I., and Bolt, E.L. (2011). Helicase
dissociation and annealing of RNA-DNA hybrids by Escherichia coli Cas3
protein. Biochem. J. 439, 85–95.
Jore, M.M., Lundgren, M., van Duijn, E., Bultema, J.B., Westra, E.R.,
Waghmare, S.P., Wiedenheft, B., Pul, U., Wurm, R., Wagner, R., et al.
(2011). Structural basis for CRISPR RNA-guided DNA recognition by
Cascade. Nat. Struct. Mol. Biol. 18, 529–536.
Karginov, F.V., and Hannon, G.J. (2010). The CRISPR system: small RNA-
guided defense in bacteria and archaea. Mol. Cell 37, 7–19.
Lintner, N.G., Kerou, M., Brumfield, S.K., Graham, S., Liu, H., Naismith, J.H.,
Sdano, M., Peng, N., She, Q., Copie´, V., et al. (2011). Structural and functional
characterization of an archaeal clustered regularly interspaced short palin-
dromic repeat (CRISPR)-associated complex for antiviral defense
(CASCADE). J. Biol. Chem. 286, 21643–21656.
Makarova, K.S., Aravind, L., Grishin, N.V., Rogozin, I.B., and Koonin, E.V.
(2002). A DNA repair system specific for thermophilic Archaea and bacteria
predicted by genomic context analysis. Nucleic Acids Res. 30, 482–496.
Makarova, K.S., Grishin, N.V., Shabalina, S.A., Wolf, Y.I., and Koonin, E.V.
(2006). A putative RNA-interference-based immune system in prokaryotes:
computational analysis of the predicted enzymatic machinery, functional anal-
ogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol.
Direct 1, 7.
Makarova, K.S., Aravind, L., Wolf, Y.I., and Koonin, E.V. (2011a). Unification of
Cas protein families and a simple scenario for the origin and evolution of
CRISPR-Cas systems. Biol. Direct 6, 38.
Makarova, K.S., Haft, D.H., Barrangou, R., Brouns, S.J., Charpentier, E.,
Horvath, P., Moineau, S., Mojica, F.J., Wolf, Y.I., Yakunin, A.F., et al.
(2011b). Evolution and classification of the CRISPR-Cas systems. Nat. Rev.
Microbiol. 9, 467–477.
Marraffini, L.A., and Sontheimer, E.J. (2008). CRISPR interference limits hori-
zontal gene transfer in staphylococci by targeting DNA. Science 322, 1843–
1845.
Marraffini, L.A., and Sontheimer, E.J. (2010a). CRISPR interference: RNA-
directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11,
181–190.
Marraffini, L.A., and Sontheimer, E.J. (2010b). Self versus non-self discrimina-
tion during CRISPR RNA-directed immunity. Nature 463, 568–571.
Mojica, F.J., Dı´ez-Villasen˜or, C., Garcı´a-Martı´nez, J., and Soria, E. (2005).
Intervening sequences of regularly spaced prokaryotic repeats derive from
foreign genetic elements. J. Mol. Evol. 60, 174–182.
Mou, T.C., Masada, N., Cooper, D.M., and Sprang, S.R. (2009). Structural
basis for inhibition of mammalian adenylyl cyclase by calcium. Biochemistry
48, 3387–3397.ts reserved
Structure
Crystal Structure of Cmr2Mulepati, S., and Bailey, S. (2011). Structural and biochemical analysis of
nuclease domain of clustered regularly interspaced short palindromic repeat
(CRISPR)-associated protein 3 (Cas3). J. Biol. Chem. 286, 31896–31903.
Nowotny, M., Gaidamakov, S.A., Crouch, R.J., and Yang, W. (2005). Crystal
structures of RNase H bound to an RNA/DNA hybrid: substrate specificity
and metal-dependent catalysis. Cell 121, 1005–1016.
Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data
collected in oscillation mode. Methods Enzymol. 276, 307–326.
Papadopoulos, J.S., and Agarwala, R. (2007). COBALT: constraint-based
alignment tool for multiple protein sequences. Bioinformatics 23, 1073–1079.
Pourcel, C., Salvignol, G., and Vergnaud, G. (2005). CRISPR elements in
Yersinia pestis acquire new repeats by preferential uptake of bacteriophage
DNA, and provide additional tools for evolutionary studies. Microbiology
151, 653–663.
Sapranauskas, R., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., and
Siksnys, V. (2011). The Streptococcus thermophilus CRISPR/Cas system
provides immunity in Escherichia coli. Nucleic Acids Res. 39, 9275–9282.
Semenova, E., Jore, M.M., Datsenko, K.A., Semenova, A., Westra, E.R.,
Wanner, B., van der Oost, J., Brouns, S.J., and Severinov, K. (2011).
Interference by clustered regularly interspaced short palindromic repeat
(CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. USA
108, 10098–10103.
Sinha, S.C., Wetterer, M., Sprang, S.R., Schultz, J.E., and Linder, J.U. (2005).
Origin of asymmetry in adenylyl cyclases: structures ofMycobacterium tuber-
culosis Rv1900c. EMBO J. 24, 663–673.Structure 20,Sinkunas, T., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., and
Siksnys, V. (2011). Cas3 is a single-stranded DNA nuclease and ATP-depen-
dent helicase in the CRISPR/Cas immune system. EMBO J. 30, 1335–1342.
Terns, M.P., and Terns, R.M. (2011). CRISPR-based adaptive immune
systems. Curr. Opin. Microbiol. 14, 321–327.
Tesmer, J.J., Dessauer, C.W., Sunahara, R.K., Murray, L.D., Johnson, R.A.,
Gilman, A.G., and Sprang, S.R. (2000). Molecular basis for P-site inhibition
of adenylyl cyclase. Biochemistry 39, 14464–14471.
Wang, R., Preamplume, G., Terns, M.P., Terns, R.M., and Li, H. (2011).
Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition
and cleavage. Structure 19, 257–264.
Wiedenheft, B., Lander, G.C., Zhou, K., Jore, M.M., Brouns, S.J., van der Oost,
J., Doudna, J.A., and Nogales, E. (2011a). Structures of the RNA-guided
surveillance complex from a bacterial immune system. Nature 477, 486–489.
Wiedenheft, B., van Duijn, E., Bultema, J.B., Waghmare, S.P., Zhou, K.,
Barendregt, A., Westphal, W., Heck, A.J., Boekema, E.J., Dickman, M.J.,
and Doudna, J.A. (2011b). RNA-guided complex from a bacterial immune
system enhances target recognition through seed sequence interactions.
Proc. Natl. Acad. Sci. USA 108, 10092–10097.
Wimberly, B.T., Brodersen, D.E., Clemons, W.M., Jr., Morgan-Warren, R.J.,
Carter, A.P., Vonrhein, C., Hartsch, T., and Ramakrishnan, V. (2000).
Structure of the 30S ribosomal subunit. Nature 407, 327–339.
Yang, W. (2011). Nucleases: diversity of structure, function and mechanism.
Q. Rev. Biophys. 44, 1–93.545–553, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 553
